0001437749-21-000725.txt : 20210114
0001437749-21-000725.hdr.sgml : 20210114
20210114163514
ACCESSION NUMBER: 0001437749-21-000725
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210113
FILED AS OF DATE: 20210114
DATE AS OF CHANGE: 20210114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bruck Claudine
CENTRAL INDEX KEY: 0001733680
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35076
FILM NUMBER: 21529132
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVE, SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017-3552
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000810509
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 311080091
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
BUSINESS PHONE: 6147937500
MAIL ADDRESS:
STREET 1: 4995 BRADENTON AVENUE
STREET 2: SUITE 240
CITY: DUBLIN
STATE: OH
ZIP: 43017
FORMER COMPANY:
FORMER CONFORMED NAME: NEOPROBE CORP
DATE OF NAME CHANGE: 19940714
4
1
rdgdoc.xml
FORM 4
X0306
4
2021-01-13
0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
0001733680
Bruck Claudine
4995 BRADENTON AVE., SUITE 240
DUBLIN
OH
43017
1
Common Stock
2021-01-13
4
A
0
2500
0.001
A
12550
D
Stock Option
2.28
2021-01-13
4
A
0
2500
0.001
A
2022-01-13
2031-01-13
Common Stock
2500
2500
D
Restricted shares granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan which vest on the one-year anniversary of the date of grant.
/s/ Jed A. Latkin for Claudine Bruck, by power of attorney
2021-01-14